• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    UFP Technologies (UFPT) Could Be 17% Undervalued As Growth Plans Come Into Focus

    Simply Wall St·09/26/2026 16:26:51
    Listen to the news

    UFP Technologies (UFPT) drew fresh attention after recent price data put the stock near a US$295.65 close, with year to date and 1 year total returns remaining firmly in positive territory.

    Recent trading has been choppy for UFP Technologies, with the share price slipping 0.95% over the last session and easing 2.93% over 30 days. However, the 7 day share price return of 6.85% and 90 day gain of 13.80% point to momentum that aligns with a much stronger backdrop, highlighted by a 1 year total shareholder return of 52.76% and a 5 year total shareholder return of 377.93%.

    Scan other fast moving healthcare manufacturers by checking our hand picked list of 38 healthcare AI stocks as a comparison point to UFP Technologies.

    After a 52.76% 1 year total return and a 5 year run that has turned early holders into clear winners, the real puzzle now is whether UFP Technologies still offers enough upside to justify fresh risk from this point.

    Most Popular Narrative: 17% Undervalued

    UFP Technologies is trading at a last close of $295.65, while the most followed narrative pegs fair value at $355. This implies a clear valuation gap based on those assumptions and a 7.45% discount rate.

    The expansion of manufacturing capacity and product development centers in the Dominican Republic, along with new program launches for robotic-assisted surgery customers, sets the stage for sustained revenue growth tied to increased demand for sophisticated medical device components and packaging solutions.

    See why 4 investors see UFP Technologies as 17% undervalued.

    Result: Fair Value of $355 (UNDERVALUED)

    Still, the UFP Technologies narrative could be knocked off course if reliance on a few large medical customers weakens, or if acquired businesses prove harder to integrate than expected.

    Find out about the key risks to this UFP Technologies narrative.

    Another View On UFP Technologies Valuation

    The first narrative leans on fair value at $355, yet the simple earnings multiple tells a cooler story. UFP Technologies trades on a P/E of 31.7x, while the fair ratio sits at 25.9x and the US Medical Equipment group sits around 25x. That lifts valuation risk rather than padding upside, so how much premium are you really willing to pay for this profile?

    For a closer look at how that earnings multiple lines up against fundamentals, and whether the current price tags on enough quality, See what the numbers say about this price — find out in our valuation breakdown.

    NasdaqCM:UFPT P/E Ratio as at Sep 2026
    NasdaqCM:UFPT P/E Ratio as at Sep 2026

    Next Steps

    Mixed feelings about UFP Technologies after all that. If you want to move quickly and rely on your own interpretation of the data, consider the 2 key rewards and 1 important warning sign.

    Looking for more investment ideas beyond UFP Technologies?

    If UFP Technologies has sharpened your appetite for opportunities, do not stop here. The next strong addition to your portfolio could already be on the radar of our screeners.

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.